Get Live Data

Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

  2. Share Prices
  3. Oxford Biomedica Share Price
  4. Oxford Biomedica Share Regulatory News
  5. Total Voting Rights Update

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Oxford Biomedica Information

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights Update

26 Feb 2010 09:14

RNS Number : 7365H
Oxford Biomedica PLC
26 February 2010
 



For Immediate Release

26 February 2010

 

 

Oxford BioMedica plc ("the Company")

 

Total Voting Rights Update

 

 

In accordance with the FSA's Disclosure and Transparency Rules, Oxford BioMedica plc (LSE:OXB) confirms that as of the date of this announcement the Company's issued share capital consists of 542,917,245 ordinary shares of 1p each, all with voting rights. No shares are held in treasury.

 

This figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

 

For further information, please contact:

Oxford BioMedica plc:

John Dawson, Chief Executive Officer

Andrew Wood, Chief Financial Officer

 

Tel: +44 (0)1865 783 000

JPMorgan Cazenove Limited:

James Mitford / Gina Gibson

 

Tel: +44 (0)20 7588 2828

City/Financial Enquiries:

Lisa Baderoon / Mark Court

Buchanan Communications

 

Tel: +44 (0)20 7466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRGCGDDDBDBGGL
101112131415161718
Date   Source Headline
3rd Mar 20157:00 amRNSTotal Voting Rights
23rd Feb 20153:36 pmRNSChief Secretary to the Treasury visits OXB
16th Feb 201511:41 amRNSChange of Registered Address
30th Jan 201510:47 amRNSTotal Voting Rights
28th Jan 20154:40 pmRNSSecond Price Monitoring Extn
28th Jan 20154:35 pmRNSPrice Monitoring Extension
31st Dec 20147:00 amRNSBLOCK LISTING RETURN
31st Dec 20147:00 amRNSTotal Voting Rights
18th Dec 20142:45 pmRNSDirector's Share Purchase.
18th Dec 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16th Dec 20143:50 pmRNSDirector PDMR Shareholding
16th Dec 20143:50 pmRNSNotification Of Major Interest In Shares
1st Dec 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
28th Nov 20147:00 amRNSTotal Voting Rights
26th Nov 20147:00 amRNSDirector Dealings
3rd Nov 20147:00 amRNSInterim Management Statement
31st Oct 20147:00 amRNSTotal Voting Rights
17th Oct 20149:27 amRNSDirector's Interest in Share Options
17th Oct 20149:10 amRNSHolding(s) in Company
16th Oct 20144:52 pmRNSDirectorate Change
15th Oct 20145:05 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
13th Oct 20147:00 amRNSOxford BioMedica Acquires Windrush Court Office
10th Oct 20147:41 amRNSAdditional Listing
10th Oct 20147:00 amRNSSecond major agreement with Novartis
28th Aug 20147:00 amRNSHalf Yearly Report
15th Aug 20147:00 amRNSPaul Blake Appointed as Chief Development Officer
7th Aug 20147:00 amRNSNotice of Results
25th Jul 20149:48 amRNSBlock listing Application
1st Jul 201410:55 amRNSOxford BioMedica plc Director's Share Purchase
30th Jun 20147:00 amRNSTotal Voting Rights Update
23rd Jun 20147:00 amRNSDirectors' Interest in Share Options
20th Jun 20142:38 pmRNSPiper Jaffray GenomeRx Symposium in New York
19th Jun 20149:50 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:01 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:00 amRNSGRANT OF AWARDS
18th Jun 201411:30 amRNSLoan Repayment in Full
18th Jun 20149:36 amRNSHolding(s) in Company
18th Jun 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jun 201412:29 pmRNSRESULT OF GENERAL MEETING AND DIRECTORS DEALING
16th Jun 20147:00 amRNSResults of firm fundraising and open offer
3rd Jun 201412:34 pmRNSResult of AGM
29th May 20144:52 pmRNSNotice of posting of prospectus
29th May 20147:00 amRNSFundraising and Open Offer
22nd May 20149:22 amRNSDirector Declaration
13th May 20147:00 amRNSInterim Management Statement
2nd May 20144:57 pmRNS2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30th Apr 20147:00 amRNS£2.2 Million Grant Received from TSB
29th Apr 20147:00 amRNSOxford BioMedica provides update on RetinoStat®
10th Apr 20147:00 amRNSFinal Results
101112131415161718

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.